Heart Rate, HF Admissions, and Readmissions

Overview

Burden of HF and Need for Reduction in Rehospitalizations

Cost of HF to Society

Challenge of Incorporating New Guideline Suggestions Into Practice

Role of Heart Rate as a CV Risk Biomarker

Role of Heart Rate as a CV Risk Factor

Effect of Ivabradine on Outcomes

SHIFT: Efficacy Summary

SHIFT: Ivabradine Improves QoL in Patients With HF

SHIFT: Heart Rate Reduction and β-Blocker Use

Initiation of Heart Rate-Lowering Therapy

Patient Selection: When to Consider Ivabradine

Ivabradine: Practical Considerations

Heart Rate Reduction: What to Expect in Patients With AF

What to Expect in Patients With High BP

What to Expect in Patients on Digoxin

What to Expect in HFpEF

Reducing the Cost of HF Therapy

Abbreviations

Abbreviations (cont)